---
title: "TCBPY.US (TCBPY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TCBPY.US/news.md"
symbol: "TCBPY.US"
name: "TCBPY.US"
parent: "https://longbridge.com/en/quote/TCBPY.US.md"
datetime: "2026-03-04T15:10:13.133Z"
locales:
  - [en](https://longbridge.com/en/quote/TCBPY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TCBPY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TCBPY.US/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/TCBPY.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/TCBPY.US/news.md)


# TCBPY.US (TCBPY.US) — Related News

### [TC BioPharm Limited Enters Administration; Joint Administrators Seek Sale of Subsidiary's Assets](https://longbridge.com/en/news/260150755.md)
*2025-10-07T11:01:01.000Z*
> TC BioPharm Limited has entered administration, with joint administrators Michael Magnay and Rob Croxen appointed to see

### [TC BioPharm reports complete response in MRD patient after 2nd dose of TCB008. First in Cohort B.Announced in Edinburgh.](https://longbridge.com/en/news/244080114.md)
*2025-06-11T12:47:22.000Z*
> A patient in Cohort B has successfully achieved complete remission after receiving their second dose of TCB008 in Edinbu

### [08:30 ET
			
			
				TC BioPharm Announces Complete Response in Minimal Residual Disease (MRD) Patient](https://longbridge.com/en/news/244075062.md)
*2025-06-11T12:30:43.000Z*
> TC BioPharm (Holdings) PLC announced that the first patient in Cohort B, who had detectable Minimal Residual Disease (MR

### [Why TC Biopharm (TCBP) Stock Is Down Over 60% Today](https://longbridge.com/en/news/232784464.md)
*2025-03-21T17:49:02.000Z*
> TC Biopharm (TCBP) shares plummeted by 64% after the company announced its transition from Nasdaq to OTC markets due to 

### [TCBP Announces Transition from Nasdaq to OTC Markets | TCBP Stock News](https://longbridge.com/en/news/232765602.md)
*2025-03-21T14:45:00.000Z*
> TC BioPharm (Holdings) PLC announced its transition from Nasdaq to OTC Markets after receiving notice of delisting due t

### [TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead | TCBP Stock News](https://longbridge.com/en/news/232242806.md)
*2025-03-18T12:03:00.000Z*
> TC BioPharm (NASDAQ: TCBP) announced outsourcing initiatives aimed at reducing its operational burn rate by 55% compared

### [TC BioPharm Reports Plan to Buy Ophthalmic Pharmaceutical Firm](https://longbridge.com/en/news/230690410.md)
*2025-03-05T15:49:25.000Z*
> TC BioPharm said Wednesday it executed a non-binding letter of intent to acquire a commercial-stage ophthalmic pharmaceu

### [TCBP CEO Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum | TCBP Stock News](https://longbridge.com/en/news/229028224.md)
*2025-02-20T13:00:00.000Z*
> TC BioPharm (NASDAQ: TCBP) announced that CEO Bryan Kobel will participate in the Cancer Progress Panel at the 18th Annu

### [European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading](https://longbridge.com/en/news/228887420.md)
*2025-02-19T16:19:57.000Z*
> European equities traded in the US saw a decline of 0.57% on the S&P Europe Select ADR Index. Notable gainers included N

### [European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading](https://longbridge.com/en/news/228224011.md)
*2025-02-13T16:09:11.000Z*
> European equities traded in the US as American depositary receipts fell 0.04% to 1,402.70 on the S&P Europe Select ADR I